Michael J. Fox Foundation Archives
Sep. 21, 2012—Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.
Feb. 1, 2012—The Center for Technology Transfer and Commercialization is taking Vanderbilt researchers’ inventions to new heights Use the term “inventor,” and what pops to mind? The wild-haired Dr. Emmett Brown and his time-traveling DeLorean? The unflappable “Q” demonstrating a laser-enabled wristwatch or an exploding attaché case? Perhaps the Absent-Minded Professor and his gooey, green “flubber”? Hollywood...
Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.